Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sodium Hyaluronate, Hyaluronic Acid Among CIR 2004 Review Priorities

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel named 17 ingredients as priorities for review next year based on frequency of use and potential biological activity during a Nov. 13-14 meeting in Washington, D.C. Ingredients placed at the top of the priority list raise both concerns, CIR Director Alan Andersen, PhD, said

You may also be interested in...

CIR Hair Dye Epidemiology Position Will Be Solidified By Early 2004

The Cosmetic Ingredient Review Expert Panel will release a hair dye epidemiology "boilerplate" stating that evidence is insufficient to prove a causal relationship exists between hair dye use and certain types by of cancer in early 2004, the panel announced

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts